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Smoking and body mass index (BMI) are well-documented risk factors that contribute substan-
tially to chronic obstructive pulmonary disease (COPD) and asthma. However, the relations
among smoking, obesity, and COPD or asthma remain to be clarified.
We conducted a population-based cross-sectional epidemiologic study to explore the associ-
ation between BMI and COPD or asthma among non-smokers, smokers and ex-smokers using in-
formation obtained from the Health Search database (HSD) owned by the Italian College of
General Practitioners (SIMG), which stores information on about 1.5% of the total Italian pop-
ulation served by general practitioners (GPs).
Our study confirms the importance of smoking status in patients with COPD, but not in those
with asthma. Moreover, it demonstrates that the increase in BMI is frequently associated with
the diagnosis of COPD or asthma, suggesting that the probability of suffering from COPD or
asthma increases with the increase in body weight regardless of the smoking status. The asso-
ciation between an increase in BMI appears to be greater in women than in men. Our data also
show that underweight is significantly associated with COPD, but only in men, while being un-
derweight apparently protects from the possibility of suffering from asthma.
ª 2013 Published by Elsevier Ltd.o di Medicina dei Sistemi, Universita` di Roma Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
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Smoking and body mass index (BMI) are well-documented
risk factors associated to chronic obstructive pulmonary
disease (COPD) and asthma.
Smoking is the major risk factor for the development of
COPD1 and has similar deleterious effects in both sexes,2
although substantial proportion of the subjects fulfilling the
criteria of COPD according to GOLD guidelines3 have never
smoked.4 Airwayobstruction in non-smokers is associatedwith
increasing age, but apparently there is no gender difference.4
The association between asthma and smoking is less clear. To
date, therehas been relatively little and somewhat conflicting
information on the long-term effects of cigarette smoking on
health outcomes among population-based cohorts of asth-
matic individuals.5 Some studies reported that smoking at any
timeorex-smoking status tobeassociatedwith asthma,with a
prevalence relatively close to that found in the general pop-
ulation.6,7 At least in adulthood, womenwho smoke appear to
bemore likely to suffer fromasthma.8However, bothRo¨nmark
etal.9 andMcHughet al.10 foundonlyex-smoking status tobea
significant risk factor for asthma. It has been suggested that
asthmatic current smokers represent a subpopulation that is
less susceptible to the effects of smoking.11
Limited epidemiologic data suggest that overweight or
obese status in men may protect them against the risk for
developing COPD, although people with COPD, mainly those
with emphysema, are at risk for low bodyweight.12e15 On the
contrary, obesity is a key factor predicting prevalence of
asthma.16 Increased body mass index (BMI) seems to be a
significant risk factor for incident asthma independent of sex
and allergic status.9 However, female sex is more common
among obese subjects with multi-symptom asthma.17
Although not very many, there are epidemiological
studies that have explored the association between BMI and
COPD or asthma among non-smokers, smokers and ex-
smokers.9,18e20 However, the relations among smoking,
obesity, and COPD or asthma remain to be clarified.
Since routinely collected primary care computer data,
aggregated into large databases, offer a rich resource for
epidemiological research,21wehave conductedapopulation-
based cross-sectional epidemiologic study by using informa-
tion obtained from the Health Search database (HSD) owned
by the Italian College of General Practitioners (SIMG), which
stores information on about 1.5% of the total Italian popula-
tion served by general practitioners (GPs) to investigate the
associationbetweentobacco smokingandBMI inadultwomen
and men suffering from COPD or asthma.
Patients and methods
Collection of information
Data were extracted from the HSD, a general practice
database that was established in 1998 and is managed by
SIMG. HSD currently contains electronic medical records of
around 1.6 million patients from over 900 GPs throughout
Italy. Details of both the HSD and data collection process
are described elsewhere.22
HSD complies with European Union guidelines on the use
of medical data for research and has been previouslydemonstrated to be a valid data source for scientific
research.22e27
Ascertainment of COPD, asthma and BMI
For this analysis we selected from HSD all subjects aged
>14 years of which information was available about the
diagnosis, BMI and smoking habit.
Cases of COPD were identified on the basis of the ICD-9
codes 491, 492, and 496, and those of asthma on the basis
of the ICD-9 code 493. Since the HSD includes univocal
classification for asthma or COPD, we could not analyze
separately patients suffering from both COPD and asthma
(overlap syndrome).
TheBMIwas calculated according to the formula ofweight
in kilograms divided by the square of the height in meters
squared (weight (kg)/[height (m)2]). It was categorized as
follows: underweight (<18.5 kg/m2), normal weight
(18.5e<25 kg/m2), overweight (25.0e<30.0 kg/m2), and
obese (30 kg/m2).28,29 Three parameters of smoking were
used as follows: current smokerswere subjects who reported
smoking cigarettes every day; former smokers were those
who reported smoking cigarettes daily in the past, but who
were not smoking from at least 12 months; otherwise, sub-
jects were classified as never-smokers.
Analysis
The study was carried out by a cross-sectional and obser-
vational field method. It permitted to describe the situation
at the time of data collection, the end of December 2011,
and it allowed determining the prevalence of investigated
outcomes.
The studied population was divided by several clusters:
respiratory disease (asthma and COPD), gender (male and
female), age (15e34, 35e44, 45e54, 55e64, 65e74, 75e84
and older than 85 years), BMI (underweight, normal weight,
overweight, and obese) and smoking status (current
smokers, former smokers, never-smokers).
Odds ratios (OR) and 95% confidence intervals (95%CI) of
asthma and COPD have been calculated in order to analyze
the correlation between these diseases, the smoking habit
and the BMI. Positive and negative OR values mean a co-
relative positive and negative association between evalu-
ated variables. Data were adjusted for gender, age, smoking
habit and BMI by Mantel-Haenszel method, that permits a
precision-based estimates of the OR. Furthermore, if the
prevalence of variables weremore than 10%, and the OR was
more than 2.5 or less than 0.5, correction of the OR was
carried out. In order to calculate statistical and epidemio-
logical values, computer software GraphPad Prism (CA, USA)
and OpenEpi (Dean AG, Sullivan KM, Soe MM. Open Source
Epidemiologic Statistics for Public Health) were used.
Results
Descriptive analysis
The total sample included 424,889 individuals, 30,089
suffering from asthma and 29,360 from COPD. Prevalence of
Table 1 Prevalence (%) of asthma and COPD considering BMI and smoking status in the study population.
Asthma prevalence COPD prevalence
Never
smokers
Current
smokers
Former
smokers
Total Never
smokers
Current
smokers
Former
smokers
Total
Underweight 6.65 6.48 5.97 6.56 1.63 8.22 9.63 3.92
Normal weight 7.17 7.35 6.40 7.12 2.52 8.91 9.26 5.13
Overweight 7.91 7.31 6.57 7.46 5.06 14.34 12.81 8.80
Obese 9.83 8.67 8.04 9.18 5.75 16.97 17.21 10.40
Total 7.92 7.53 6.85 7.62 3.99 11.94 12.64 7.42
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COPD was 7.42%. Asthma was more prevalent in women,
whereas COPD was more prevalent in men (data not
shown). The prevalence of COPD was higher in overweight
and obese population than in underweight and normal
weight subjects, whereas the prevalence of asthma was
higher only in obese population. As expected, the smoking
habit did not modify the prevalence of asthma but it
influenced the prevalence of COPD (Table 1).
The analysis of proportions of population subsets evi-
dences that in both COPD and asthma, more than half of
patients had an excess of body weight irrespective of
gender. While in patients with COPD, the majority of pa-
tients were current or former smokers regardless of BMI,
the majority of asthmatics were never-smokers. Interest-
ingly, approximately 30% COPD patients in all categories of
BMI had never smoked.
Analysis of effect size and strength of association
The diagnosis of asthma was significantly associated with
BMI regardless of smoking status, except in former smokersFigure 1 Adjusted odds ratios and 95% confidence intervals of as
have been adjusted for gender and age; *P < 0.05, **P < 0.01 and ***
Y axis at 1.0 value).with underweight (P > 0.05). Apparently, the subjects who
were underweight were "protected" (OR never-smokers
0.83 and 95%CI 0.73e0.94, OR current smokers 0.77 and
95%CI 0.64e0.92; P < 0.01) while the overweight and obese
people seemed at increased risk (Fig. 1A).
A subset analysis for the influence of smoking habit and
BMI in asthma documented that the association with a
diagnosis of asthma was significantly (P < 0.05) higher in
women (OR 1.33 and 95%CI 1.22e1.44) than in men (OR 0.98
and 95%CI 0.89e1.08), mainly in the overweight or obese
clusters. Apparently, age did not interfere on this evidence
(P > 0.05) (Fig. 2A).
The BMI modulated the association with a diagnosis if
COPD in all classes of smoking, except in never-smokers
with underweight (P > 0.05). An abnormal BMI was associ-
ated with COPD, regardless of the smoking habit (Fig. 1B).
Also for COPD, the subset analysis for the influence of
smoking habit and BMI showed that the association with a
clinical diagnosis of COPD was slightly higher in women (OR
1.84 and 95%CI 1.66e2.03) than in men (OR 1.63 and 95%CI
1.48e1.78), and this especially in overweight or obese
subjects, whereas men in underweight were those who hadthma (A) or COPD (B) clustered by BMI and smoking habit. Data
P < 0.001 vs normal weight population (dotted line intercepting
Figure 2 Subset analysis by age and smoking habit for the correlation between BMI and asthma (A, B, C) or COPD (D, E, F). Data
shown have been adjusted for gender and they represent exclusively the main significant (P < 0.05) odds ratios and 95% confidence
intervals of asthma or COPD vs the normal weight population. Data not shown were not statistically significant (P > 0.05).
1420 M. Cazzola et al.a stronger association with COPD if they were current or
former smokers. Age significantly influenced the correlation
with COPD only in the age cluster 15e35 years of current
smokers (Fig. 2B).Discussion
To the best of our knowledge, this is the first study that has
investigated the impact of BMI on COPD or asthma while
taking into account the smoking habit in the same large
population. Our results demonstrate that an increase in BMI
is frequently associated with the diagnosis of COPD or
asthma, suggesting that the probability of suffering from
these diseases increases with the increase in body weight
regardless of the smoking status. The association between
an increase in BMI and COPD or asthma appears to be
greater in women than in men. Our data also show that
underweight is significantly associated with COPD in men,
while being underweight apparently protects from the
possibility of suffering from asthma. Interestingly, our study
confirms the importance of smoking status in patients with
COPD, but not in those with asthma.
Whether the association between BMI and COPD or
asthma is coincidental or due to a true physiologic linkremains unclear. Several studies indicated that both COPD
and asthma are associated with systemic inflammation.30
The role for smoking-related systemic inflammation is
patent in COPD,31 but it is less clear in asthma.32 Our results
seem to exclude a modulatory role of smoking on the
impact of BMI both in COPD and asthma. Consequently, it is
likely that other triggers can explain the role of BMI that we
observed in both diseases. Potential mechanistic links be-
tween adipose tissue mass and systemic inflammation in
patients with COPD33 and asthma34 have been suggested,
but solid evidence is still lacking.
A major strength of the present study is that it provided
comprehensive data that allowed us to investigate the de-
gree of relationship between BMI and the clinical diagnosis
of COPD or asthma among nonsmokers, smokers and ex-
smokers in a large population.
However, our study has several potential limitations that
are common to all retrospective database analyses but
must be acknowledged and that we have already high-
lighted in other studies in which we evaluated data
included in the HSD.22e27
These limitations might be associated mainly with bias
toward the selection of more highly motivated, or better
organized, practices. Consequently, our findings might
likely be an overestimate of the general picture on the one
Role of BMI and smoke in COPD 1421hand. Nonetheless, on the other hand, it is well known that
patients vary in their use of health care and it is accepted
that a significant proportion of patients who are ill may not
consult their doctor and this can lead to underestimation of
the problem. Moreover, we cannot deny that there may
have been misclassification when our GPs have used specific
diagnostic categories.
In the majority of our patients, the diagnosis of COPD or
asthma was mainly clinical and this is, likely the most
important limitation of our study that we cannot overcome
because, unfortunately, Italian GPs make little use of
spirometry in their investigation of chronic respiratory
symptoms.35 In fact, only one third of patients with COPD
and less than 20% of those with asthma had spirometry
records. In any case, we must mention that in the analysis
of Feary et al.36 that used data from primary care to
investigate the prevalence of major comorbidities in sub-
jects with COPD, no clinically important difference was
seen in the results after excluding patients with COPD but
without spirometry records from the analysis.
We must also highlight that this was not a longitudinal
study, but a cross-sectional analysis that examined the
population at a given time. Therefore, it only provided the
frequency and characteristics of the diseases in this popu-
lation as they were at the time of the evaluation. Conse-
quently, our results do not allow us to understand whether
BMI and smoking status might be triggers or causal factors
of COPD and asthma and if and when they overlap each
other. In any case, our results showed a significant effect
size association between BMI and COPD or asthma regard-
less the smoking habit.
In conclusion, the evidence of the importance of BMI in
COPD and asthma clearly indicate that we must definitely
look beyond smoking and also, probably, atopy when we
manage patients suffering from these diseases.
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